Pharmaceutical Business Review 4 weeks ago

Aurobindo Pharma Obtains Final Approval From FDA For Lamotrigine Tablets

Aurobindo Pharma (Aurobindo) has received the final approval for Lamotrigine tablets (chewable, dispersible) 5mg and 25mg from the FDA. Lamotrigine tablets 5mg and 25mg is generic equivalent to Limictal CD Tablets 5mg and 25mg of GlaxoSmithKline (GSK). Full Article at Pharmaceutical Business Review

Related Topics:

  1. US Food and Drug Administration
  2. GlaxoSmithKline Inc
  3. NutriSystem Inc

Related Articles

  1. New Kerala logo
    Aurobindo Pharma gets US FDA nod for Lamotrigine tablets
    4 weeks ago

    New Delhi, Nov 6 : Drug maker Aurobindo Pharma Ltd today said it has got the received the final approval for Lamotrigine Tablets (Chewable, Dispersible) 5mg and 25mg from the US Food and Drug Administration (US FDA). Full Article at New Kerala

  2. Business Standard logo
    Aurobindo Pharma gets USFDA approval
    4 weeks ago

    With this latest approval, the pharma major has a total of 107 approvals from USFDA in its kitty. Lamotrigine tablets 5mg and 25mg is generic equivalent to Lamictal CD tablets 5 mg and 25 mg of GlaxoSmithKline, the compay said in a statement today. Full Article at Business Standard

Related Quotes

There are no results for this module. Edi the module to change the search term used to query related quotes.

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
    prev
    next
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

Browse More Photos

Daylife is the web's largest archive of news photos

  1. St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta(TM) surgical lead for neurostimulation therapy.
  2. WASHINGTON - JUNE 12: University of Florida's Emerging Pathogens Institute Director Glenn Morris testifies before the House Subcommittee on Oversight and Investigations June 12, 2008 in Washington, DC.
  3. WASHINGTON - APRIL 22: Commissioner of the Food and Drug Administration Andrew von Eschenbach testifies during a hearing before the Subcommittee on Oversight and Investigations of the House Energy & Commerce Committee April 22, 2008 on Capitol Hill in Washington, DC.
  4. A nurse prepares a shot of the A(H1N1) vaccine (Pandemrix from Glaxo Smith Kline -GSK- laboratory) to a hospital staff member in Istanbul, on November 2, 2009.

Cast of Characters

  1. US Food and Drug Administration US Food and Drug Administration
  2. GlaxoSmithKline Inc GlaxoSmithKline Inc
  3. NutriSystem Inc
  4. Bombay Stock Exchange Bombay Stock Exchange